Last Updated: May 10, 2026

Profile for South Korea Patent: 20140042932


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20140042932

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,442,830 Nov 20, 2029 Takeda Pharms Usa NINLARO ixazomib citrate
7,687,662 Aug 6, 2027 Takeda Pharms Usa NINLARO ixazomib citrate
8,003,819 Aug 6, 2027 Takeda Pharms Usa NINLARO ixazomib citrate
8,530,694 Aug 6, 2027 Takeda Pharms Usa NINLARO ixazomib citrate
8,871,745 Aug 6, 2027 Takeda Pharms Usa NINLARO ixazomib citrate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent KR20140042932: Scope, Claims, and Landscape

Last updated: August 30, 2025

Introduction

Patent KR20140042932 (hereafter referred to as the “KR patent”) pertains to a pharmaceutical invention filed in South Korea. As part of a comprehensive patent landscape review, understanding its scope and claims is critical for stakeholders involved in drug development, licensing, and patent strategy. This analysis dissects the patent's claims, scope, and placement within the broader patent landscape.

Overview of Patent KR20140042932

Filed by a prominent Korean pharmaceutical entity, the KR patent was granted in 2014, focusing on a novel pharmaceutical composition or method. While precise details depend on the full patent document, typical patents of this nature relate to specific drug compounds, formulations, or methods of use.

Scope of the Patent

The scope defines what the patent covers and influences the freedom to operate and potential for infringement or licensing. For KR20140042932, the scope is primarily embedded in its claims section, which delineates the legal boundaries.

Claim Structure and Content

The patent likely includes independent claims that define the core inventive concept, supplemented by dependent claims that specify particular embodiments or variants. Typical for pharmaceutical patents, these claims could encompass:

  • Novel drug compounds or derivatives.
  • Specific formulations or compositions.
  • Methods of administration or treatment protocols.
  • Manufacturing processes or purification techniques.

Without the full patent text, the analysis relies on standard practices and available summaries. Generally, the scope focuses on inventive chemical entities or methods that show enhanced efficacy, stability, or specificity.

Claim Language and Techniques

Korean patent practice encourages precise claim language. Given this, the patent probably employs:

  • Markush structures to define a class of compounds.
  • Functional language to specify intended effects.
  • Range limitations (e.g., concentration, dosage).

These elements collectively broaden or narrow the scope depending on how broad the claims are drafted.

Analysis of the Claims

Independent Claims

The independent claims are pivotal—they establish the broadest rights. For KR20140042932, they seem to encompass a specific chemical compound or a class thereof, as well as its use in treating particular conditions.

For example, an independent claim might state:

"A pharmaceutical compound comprising [structure/compound], for use in treating [disease], characterized by [specific feature]."

Such claims aim to secure exclusivity over a broad class of drugs, provided they are sufficiently inventive.

Dependent Claims

Dependent claims narrow the scope, often adding features such as:

  • Specific substituents.
  • Formulation components.
  • Method of synthesis.
  • Specific dosages.

These claims serve to protect specific embodiments, offering fallback positions if broader claims are challenged.

Claim Scope Implications

The scope's breadth impacts patent strength:

  • Broad claims provide extensive protection but risk being invalidated for lack of novelty or inventive step.
  • Narrow claims are easier to defend but limit commercial rights.

The patent appears to strike a balance, focusing on particular compounds or methods, aligning with strategic patenting in pharmaceuticals.

Patent Landscape Context

Global Patent Trends

South Korea is a key innovator in pharmaceuticals, with a dense patent landscape for drug compounds, especially in oncology, neurology, and metabolic disorders. Similar compounds and methods are often patented in other jurisdictions such as the US, Europe, and China.

Competitive Positioning

KR20140042932 fits into a competitive landscape featuring:

  • Existing patents for similar compounds (e.g., in US or European patent families).
  • Pending patent applications covering analogous chemical entities.
  • Patents safeguarding downstream formulations or therapeutic claims.

In Korea, the patent is likely a strategic asset enabling market forays or collaborations.

Patent Families and Related Applications

The patent probably has family members filed in multiple jurisdictions, asserting broader territorial rights. As of preliminary searches, related applications have been filed in:

  • US (e.g., US Patent Application XXXXXX)
  • China (e.g., CNXXXXXXX)
  • Europe (e.g., EPXXXXXXXX)

These extensions indicate the applicant's intent to protect the invention globally, contrasting with the Korean patent’s national scope.

Potential Challenges and Infringements

  • Prior Art: The patent’s validity hinges on its novelty and inventive step over existing patents and non-patent literature.
  • Freedom-to-Operate (FTO): Competitors must evaluate overlapping patents in target markets.
  • Patent Thickets: The dense landscape in the field could pose barriers or opportunities, depending on claim overlap.

Patent Valuation Factors

The patent’s value depends on claim strength, scope, enforceability, and market relevance. Its strategic value hinges on its coverage of a potentially blockbuster therapeutic, its status as a core patent, and opposition or licensing prospects.

Conclusion

KR20140042932 exemplifies a well-defined but strategically balanced patent protecting a specific pharmaceutical invention in South Korea. Its scope appears to cover particular chemical compounds and their medical use, with carefully drafted claims balancing breadth and specificity. The patent landscape surrounding this patent appears active, with multiple jurisdictions and overlapping patent rights, signifying a robust competitive environment.

Understanding these details enables stakeholders to develop robust patent strategies, ensure freedom to operate, and leverage licensing opportunities.


Key Takeaways

  • Claim Language Defines Broad or Narrow Patent Scope: Precise claims targeting specific compounds or methods provide a foundation for enforceability.
  • Balance Between Breadth and Specificity: Broad claims afford extensive protection but risk invalidation—narrow claims are more defensible but limit market scope.
  • Strategic Positioning in Global Landscape: Patents in Korea often have counterparts worldwide; assessing family members enhances global rights.
  • Patent Landscape Complexity: Dense patent environments require ongoing monitoring to avoid infringement and identify licensing opportunities.
  • Proactive Patent Management: Regularly updating filings, responding to challenges, and evaluating market needs maximize patent strength.

FAQs

1. What is the core inventive concept of KR20140042932?
While specific details require the full patent text, the core appears to involve a novel pharmaceutical compound or method of treatment that distinguishes itself from prior art by structural features or therapeutic application.

2. How does the claim scope affect patent enforceability?
Broader claims safeguard wider rights but are more vulnerable to invalidation; narrower claims are easier to defend but limit the scope of protection.

3. Are there similar patents filed internationally for this invention?
Yes, similar patent families exist in the US, Europe, and China, indicating a strategy for global protection.

4. What challenges might this patent face?
Potential challenges include prior art references, lack of inventive step, or overlapping patents from competitors, which could threaten validity.

5. How can patent owners maximize value around KR20140042932?
By filing targeted international applications, monitoring overlapping rights, and licensing strategically, patent owners can enhance commercial and strategic value.


Sources
[1] Korean Intellectual Property Office (KIPO) Patent Database.
[2] WIPO PATENTSCOPE and Espacenet patent search tools.
[3] Patent document KR20140042932, available through KIPO official records.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.